Evidence map›Paper›PMID 41922308›Full record

ArticleOncogenesis2026

Alternatively activated macrophages cause DNA damage through an arginase 1-mediated bystander effect and promote epithelial cell transformation.

Ram Babu Undi, Michael M Sutton, Evan Becker, Marie Gordon, Sara K Vesely, Samantha Ricketts, Rameswari Velayutham, William M Tierney, Courtney W Houchen, Naushad Ali and 1 more

Abstract read
In one paragraph

Article in Oncogenesis, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Ram Babu UndiDepartment of Radiation Oncology, University of Oklahoma Health Sciences Center Oklahoma City, Oklahoma City, OK, 73104, USA.
Michael M SuttonSection of Digestive Diseases and Nutrition in the Department of Internal Medicine, University of Oklahoma Health Sciences Center Oklahoma City, Oklahoma City, OK, 73104, USA.
Evan BeckerDepartment of Biostatistics and Epidemiology in the Hudson College of Public Health, University of Oklahoma Health Sciences Center Oklahoma City, Oklahoma City, OK, 73104, USA.
Marie GordonDepartment of Biostatistics and Epidemiology in the Hudson College of Public Health, University of Oklahoma Health Sciences Center Oklahoma City, Oklahoma City, OK, 73104, USA.
Sara K VeselyDepartment of Biostatistics and Epidemiology in the Hudson College of Public Health, University of Oklahoma Health Sciences Center Oklahoma City, Oklahoma City, OK, 73104, USA.
Samantha RickettsDepartment of Pathology, University of Oklahoma Health Sciences Center Oklahoma City, Oklahoma City, OK, 73104, USA.
Rameswari VelayuthamDepartment of Pathology, University of Oklahoma Health Sciences Center Oklahoma City, Oklahoma City, OK, 73104, USA.
William M TierneySection of Digestive Diseases and Nutrition in the Department of Internal Medicine, University of Oklahoma Health Sciences Center Oklahoma City, Oklahoma City, OK, 73104, USA.
Courtney W HouchenSection of Digestive Diseases and Nutrition in the Department of Internal Medicine, University of Oklahoma Health Sciences Center Oklahoma City, Oklahoma City, OK, 73104, USA.
Naushad AliSection of Digestive Diseases and Nutrition in the Department of Internal Medicine, University of Oklahoma Health Sciences Center Oklahoma City, Oklahoma City, OK, 73104, USA.
Mark M HuyckeDepartment of Radiation Oncology, University of Oklahoma Health Sciences Center Oklahoma City, Oklahoma City, OK, 73104, USA. Mark-Huycke@ou.edu.ORCID http://orcid.org/0000-0002-6110-5629

Funding

Tissue Pathology Shared ResourceP30CA225520 · NCI · UNIVERSITY OF OKLAHOMA HLTH SCIENCES CTR · PI Wade Williams · 2018 to 2026
$27.1M
TUMOR RESISTANCE MECHANISMS TO ANTI-VEGF THERAPY IN PROSTATE CANCER (Sukyung Woo)P20GM103639 · NIGMS · UNIVERSITY OF OKLAHOMA HLTH SCIENCES CTR · PI DHANASEKARAN, DANNY N. · 2012 to 2022
$21.3M
U.S. Department of Health & Human Services | National Institutes of Health (NIH) 1R01CA230641U.S. Department of Health & Human Services | National Institutes of Health (NIH) P20GM103639U.S. Department of Health & Human Services | National Institutes of Health (NIH) P30CA225520
6 · The paper itself

Abstract

Colorectal oncogenesis involves progressive genetic and epigenetic alterations in colon epithelial cells. Classically activated M1 macrophages can generate bystander-induced mutations and neoplastic transformation in epithelial cells. Herein, we report a novel mechanism by which alternatively activated M2 macrophages also induce a bystander effect. Similar to M1 macrophages, M2-activated macrophages cause double-strand DNA breaks in targeted epithelial cells, activate multiple signaling pathways, induce a DNA repair response, and transform epithelial cells in vitro. The M2-induced bystander effect occurs through an arginase 1-mediated mechanism. This enzyme is secreted by M2 macrophages and increases extracellular L-ornithine that is imported by target cells. This leads to increased polyamine metabolism and intracellular hydrogen peroxide causing DNA damage. Arginase 1-positive M2-like macrophages were frequently detected in preneoplastic colon adenomas using multiplex immunofluorescence. A greater proportion of activated macrophages was noted in histologically normal colon than in adenomas or stage I colorectal cancer. In addition to M1-like and M2-like activated macrophages, many macrophages in the colon biopsies expressed a hybrid M1/M2 phenotype. Activated macrophages significantly correlated with double-strand DNA damage in colon epithelial cells and DNA damage repair response. These findings define a novel M2-induced bystander effect and support a role for activated macrophages in colorectal cancer initiation and progression.

Identifiers

PMID41922308
PMCPMC13168261

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.